AI-generated summary
The authors retrospectively compared adverse events in 2,282 patients given intense pulsed light combined with meibomian gland expression and 1,407 given expression alone for meibomian gland dysfunction. The authors report an incidence of 3.24% for the combined treatment and 1.92% for expression alone, with no serious adverse events in either group. Because the study was retrospective, causal conclusions are limited.
- Who or what was studied
- Patients with meibomian gland dysfunction treated at Wuhan Aier Hankou Eye Hospital from February 2018 to October 2019
- Limits stated in the abstract
- The study was retrospective, so the adverse event comparison is observational and causal conclusions are not supported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Myopia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.